Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework

LD de Hosson; LM van Veenendaal; Y Schuller; Wouter Zandee; W.W. de Herder; MET Tesselaar; HJ Klumpen; AME Walenkamp

doi:10.1093/annonc/mdx547

Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework

LD de Hosson, LM van Veenendaal, Y Schuller, Wouter Zandee, W.W. de Herder, MET Tesselaar, HJ Klumpen, AME Walenkamp

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

9 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	3022-3027
Number of pages	6
Journal	Annals of Oncology
Volume	28
Issue number	12
DOIs	https://doi.org/10.1093/annonc/mdx547
Publication status	Published - 2017

Access to Document

10.1093/annonc/mdx547

http://hdl.handle.net/1765/104778

Cite this

de Hosson, LD., van Veenendaal, LM., Schuller, Y., Zandee, W., de Herder, W. W., Tesselaar, MET., Klumpen, HJ., & Walenkamp, AME. (2017). Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework. Annals of Oncology, 28(12), 3022-3027. https://doi.org/10.1093/annonc/mdx547

@article{74a27a0858b9403ab5025d1e780e4ef9,

title = "Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework",

author = "{de Hosson}, LD and {van Veenendaal}, LM and Y Schuller and Wouter Zandee and {de Herder}, W.W. and MET Tesselaar and HJ Klumpen and AME Walenkamp",

year = "2017",

doi = "10.1093/annonc/mdx547",

language = "Undefined/Unknown",

volume = "28",

pages = "3022--3027",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd.",

number = "12",

}

de Hosson, LD, van Veenendaal, LM, Schuller, Y, Zandee, W, de Herder, WW, Tesselaar, MET, Klumpen, HJ & Walenkamp, AME 2017, 'Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework', Annals of Oncology, vol. 28, no. 12, pp. 3022-3027. https://doi.org/10.1093/annonc/mdx547

TY - JOUR

T1 - Clinical benefit of systemic treatment in patients with advanced pancreatic and gastrointestinal neuroendocrine tumours according to ESMO-MCBS and ASCO framework

AU - de Hosson, LD

AU - van Veenendaal, LM

AU - Schuller, Y

AU - Zandee, Wouter

AU - de Herder, W.W.

AU - Tesselaar, MET

AU - Klumpen, HJ

AU - Walenkamp, AME

PY - 2017

Y1 - 2017

U2 - 10.1093/annonc/mdx547

DO - 10.1093/annonc/mdx547

M3 - Article

VL - 28

SP - 3022

EP - 3027

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 12

ER -